SHANDONG XINHUA PHARMACEUTICAL Co., Ltd.
SHANDONG XINHUA PHARMACEUTICAL Co., Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd. as the largest antipyretic and analgesic drug production base worldwide, have started international business since 1992, with around 30 years` experience on international business.
Nowadays Shandong Xinhua has established close strategic partnerships with Bayer, Johnson & Johnson, GlaxoSmithKline, Pfizer and other multi-international pharmaceutical giants, the annual export volume have increased from the initial 2 million USD to more than 350 million USD.
Shandong Xinhua is top 5 exporting company of APIs and top 10 exporting company of finished dosages/products in China. All products have passed GMP certification, the facilities have passed site-inspection by US FDA, UK MRHA and EU EDQM. Shandong Xinhua have focused on pharmaceutical industry almost 80 years, with integrated production line from intermediates, APIs and finished dosages/products.
In 2018, the new finished products facility with a capacity of 25 billion tablets was launched and put into production, with US FDA site inspection approval and UK MHRA GMP approval, it is playing an very important role on either contract manufacturing with or Bayer, Pfizer, Roche, DSM, and Perrigo own-labeled products for US and EU market.
The PDF has been encrypted, and you need to enter the password for normal access.
We provide PDF for you to look at the catalog, and you need to provide an email address.